Bristol-Myers Squibb
Developing Program Strategy
Bristol-Myers Squibb, one of the largest pharmaceutical companies in the world, determined that female consumers are the company's most important constituency through market research. They fill most of the prescriptions for the family and they are the primary customers for the company's retail products. It is also widely known that women's specific health care needs have been dramatically under researched given that almost all human research subjects were drawn from the military or prison populations--overwhelmingly male groups.
TCC Group helped create a new global grantmaking initiative which contributed to important breakthroughs in bio-medical research in women's health while addressing a critical business interest.
Launching a Competitive Grant Program
The assignment was to work with a first rate in-house advisory panel of scientists to identify major opportunities to shed light on how women were affected by major diseases. Leading academically-based research centers paired with a community-based healthcare organization were identified to compete for grants.
The program was implemented in the United States and overseas and received recognition for its effectiveness and innovation. John Damonti, President of the Bristol-Myers Squibb Foundation, stated that "[TCC] provided highly innovative and resourceful support in helping us launch one of our flagship programs under our Women's Health Education initiative. Working through a Request for Proposal process, TCC assisted us in identifying outstanding grantee partners in the United States, Eastern Europe and Latin America."
